These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 21665946)

  • 1. Characterization of sparstolonin B, a Chinese herb-derived compound, as a selective Toll-like receptor antagonist with potent anti-inflammatory properties.
    Liang Q; Wu Q; Jiang J; Duan J; Wang C; Smith MD; Lu H; Wang Q; Nagarkatti P; Fan D
    J Biol Chem; 2011 Jul; 286(30):26470-9. PubMed ID: 21665946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of Sparstolonin B, a selective TLR2 and TLR4 antagonist, on mouse endotoxin shock.
    Liang Q; Dong S; Lei L; Liu J; Zhang J; Li J; Duan J; Fan D
    Cytokine; 2015 Oct; 75(2):302-9. PubMed ID: 25573805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sparstolonin B attenuates hypoxia-reoxygenation-induced cardiomyocyte inflammation.
    Liu Q; Wang J; Liang Q; Wang D; Luo Y; Li J; Janicki JS; Fan D
    Exp Biol Med (Maywood); 2014 Mar; 239(3):376-84. PubMed ID: 24477822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of p38 and ERK1/2 pathways by Sparstolonin B suppresses inflammation-induced melanoma metastasis.
    Tang YM; Cao QY; Guo XY; Dong SH; Duan JA; Wu QN; Liang QL
    Biomed Pharmacother; 2018 Feb; 98():382-389. PubMed ID: 29276966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sparstolonin B suppresses lipopolysaccharide-induced inflammation in human umbilical vein endothelial cells.
    Liang Q; Yu F; Cui X; Duan J; Wu Q; Nagarkatti P; Fan D
    Arch Pharm Res; 2013 Jul; 36(7):890-6. PubMed ID: 23604718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sparstolonin B selectively suppresses toll‑like receptor‑2 and ‑4 to alleviate neuropathic pain.
    Jin G; Jin X; Zhou S
    Mol Med Rep; 2018 Jan; 17(1):1247-1252. PubMed ID: 29115627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sparstolonin B attenuates early liver inflammation in experimental NASH by modulating TLR4 trafficking in lipid rafts via NADPH oxidase activation.
    Dattaroy D; Seth RK; Das S; Alhasson F; Chandrashekaran V; Michelotti G; Fan D; Nagarkatti M; Nagarkatti P; Diehl AM; Chatterjee S
    Am J Physiol Gastrointest Liver Physiol; 2016 Apr; 310(7):G510-25. PubMed ID: 26718771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of Toll-like receptors by Burkholderia pseudomallei.
    West TE; Ernst RK; Jansson-Hutson MJ; Skerrett SJ
    BMC Immunol; 2008 Aug; 9():46. PubMed ID: 18691413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bupivacaine inhibits the TLR4- and TLR2-Myd88/NF-κB pathways in human leukocytes.
    Binczak M; Purenne E; Beloeil H; Benhamou D; Mazoit JX
    Fundam Clin Pharmacol; 2023 Apr; 37(2):347-358. PubMed ID: 36191347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidized phospholipid inhibition of toll-like receptor (TLR) signaling is restricted to TLR2 and TLR4: roles for CD14, LPS-binding protein, and MD2 as targets for specificity of inhibition.
    Erridge C; Kennedy S; Spickett CM; Webb DJ
    J Biol Chem; 2008 Sep; 283(36):24748-59. PubMed ID: 18559343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain.
    Kawamoto T; Ii M; Kitazaki T; Iizawa Y; Kimura H
    Eur J Pharmacol; 2008 Apr; 584(1):40-8. PubMed ID: 18299127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sparstolonin B inhibits lipopolysaccharide-induced inflammation in 3T3-L1 adipocytes.
    Wang M; Xiu L; Diao J; Wei L; Sun J
    Eur J Pharmacol; 2015 Dec; 769():79-85. PubMed ID: 26522926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. M2000 (β-D-Mannuronic Acid) as a Novel Antagonist for Blocking the TLR2 and TLR4 Downstream Signalling Pathway.
    Aletaha S; Haddad L; Roozbehkia M; Bigdeli R; Asgary V; Mahmoudi M; Mirshafiey A
    Scand J Immunol; 2017 Feb; 85(2):122-129. PubMed ID: 27943385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-regulated chimeric receptor approach reveals distinctive subcellular localization and signaling properties of the Toll-like receptors.
    Nishiya T; DeFranco AL
    J Biol Chem; 2004 Apr; 279(18):19008-17. PubMed ID: 14976215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of alternaramide on inflammatory mediator expression through TLR4-MyD88-mediated inhibition of NF-кB and MAPK pathway signaling in lipopolysaccharide-stimulated RAW264.7 and BV2 cells.
    Ko W; Sohn JH; Jang JH; Ahn JS; Kang DG; Lee HS; Kim JS; Kim YC; Oh H
    Chem Biol Interact; 2016 Jan; 244():16-26. PubMed ID: 26620692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components.
    Dobrovolskaia MA; Medvedev AE; Thomas KE; Cuesta N; Toshchakov V; Ren T; Cody MJ; Michalek SM; Rice NR; Vogel SN
    J Immunol; 2003 Jan; 170(1):508-19. PubMed ID: 12496438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pellino-1 Positively Regulates Toll-like Receptor (TLR) 2 and TLR4 Signaling and Is Suppressed upon Induction of Endotoxin Tolerance.
    Murphy M; Xiong Y; Pattabiraman G; Qiu F; Medvedev AE
    J Biol Chem; 2015 Jul; 290(31):19218-32. PubMed ID: 26082489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RP105 involved in activation of mouse macrophages via TLR2 and TLR4 signaling.
    Liu B; Zhang N; Liu Z; Fu Y; Feng S; Wang S; Cao Y; Li D; Liang D; Li F; Song X; Yang Z
    Mol Cell Biochem; 2013 Jun; 378(1-2):183-93. PubMed ID: 23483427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysophosphatidylcholine triggers TLR2- and TLR4-mediated signaling pathways but counteracts LPS-induced NO synthesis in peritoneal macrophages by inhibiting NF-κB translocation and MAPK/ERK phosphorylation.
    Carneiro AB; Iaciura BM; Nohara LL; Lopes CD; Veas EM; Mariano VS; Bozza PT; Lopes UG; Atella GC; Almeida IC; Silva-Neto MA
    PLoS One; 2013; 8(9):e76233. PubMed ID: 24312681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The novel small-molecule antagonist MMG-11 preferentially inhibits TLR2/1 signaling.
    Grabowski M; Murgueitio MS; Bermudez M; Wolber G; Weindl G
    Biochem Pharmacol; 2020 Jan; 171():113687. PubMed ID: 31678495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.